Source: Experimental Cell Research. Unidade: FMRP
Subjects: CÉLULAS ESTROMAIS, MEDULA ÓSSEA, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), NEOPLASIAS
ABNT
SOUZA, Lucas E. B. et al. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b+ myeloid cells to the lungs and facilitates B16-F10 melanoma colonization. Experimental Cell Research, v. 345, n. 2, p. 141-149, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.yexcr.2015.05.021. Acesso em: 18 jun. 2024.APA
Souza, L. E. B., Almeida, D. C., Yaochite, J. N. U., Covas, D. T., & Fontes, A. M. (2016). Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b+ myeloid cells to the lungs and facilitates B16-F10 melanoma colonization. Experimental Cell Research, 345( 2), 141-149. doi:10.1016/j.yexcr.2015.05.021NLM
Souza LEB, Almeida DC, Yaochite JNU, Covas DT, Fontes AM. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b+ myeloid cells to the lungs and facilitates B16-F10 melanoma colonization [Internet]. Experimental Cell Research. 2016 ; 345( 2): 141-149.[citado 2024 jun. 18 ] Available from: https://doi.org/10.1016/j.yexcr.2015.05.021Vancouver
Souza LEB, Almeida DC, Yaochite JNU, Covas DT, Fontes AM. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b+ myeloid cells to the lungs and facilitates B16-F10 melanoma colonization [Internet]. Experimental Cell Research. 2016 ; 345( 2): 141-149.[citado 2024 jun. 18 ] Available from: https://doi.org/10.1016/j.yexcr.2015.05.021